Breast Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Breast Cancer, including details on symptoms, genetics, screening, treatment, information. | ||||||||
|
The effects of intrafraction motion on dose homogeneity in a breast phantom with physical wedges, enhanced dynamic wedges, and ssIMRT.Sidhu S, Sidhu NP, Lapointe C, Gryschuk G Department of Medical Physics, Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada. Sabeena.Sidhu@sci.monash.edu.au PURPOSE: This study attempts to compare how breathing motion affects intact-breast cancer patients between three different treatment techniques and to determine the degree of improvement on dose homogeneity when implementing gating therapy. METHODS AND MATERIALS: A breast phantom and respiratory simulator were designed to simulate respiratory motion to a first-order approximation. Film was used as a dosimeter, and static dosimetry data were used as a control for comparison. Three velocities of the breast phantom were studied, and gating therapy was introduced for each data set. Dose area histograms (DAHs) were calculated for a breast and a "lung" planning target area (PTA), and Normalized Agreement Test (NAT) indices were calculated in reference to the static case. RESULTS: Deviations from the static case were highest if the collimator speed was of the same magnitude as the speed of the target. In general, gating therapy improved dose uniformity to the breast PTA by up to 14% and reduced dose to the "lung" PTA by up to 24%. With step-and-shoot intensity-modulated radiation therapy (ssIMRT), gating the beam may compromise dose coverage of the breast PTA if the timing interval of the gate is too large. Gating the beam decreased NAT indices by 9 for physical wedges, by 16 for enhanced dynamic wedges, and by 6 for ssIMRT. CONCLUSIONS: Both the phantom and respiratory simulator are adequate for showing differences in dose distributions for all three treatment modalities. Gating therapy improves dose homogeneity to the PTAs and decreases the dose delivered to areas below the posterior border of the beams. Published 14 August 2006 in Int J Radiat Oncol Biol Phys, 66(1): 64-75.
© 2004-2008 Breast Cancer Research Today. All Rights Reserved. |
| ||||||
